01 Next-Generation EBUS Designs Simplifying Pulmonary Diagnosis Complex lung and lymph-node assessment is placing more focus on bronchoscope designs that combine ultrasound guidance with clearer access to target areas. This transition is bringing slimmer distal sections, improved ultrasound interfaces, and simplified tip designs into EBUS procedures; Fujifilm launched the EB-710US in 2026 with a balloon-less design intended to improve visibility during peripheral lung examination. The outcome is a more streamlined diagnostic workflow, easier tissue targeting, and stronger integration between imaging and biopsy procedures.
02 Specimen Collection Becoming Integrated with Bronchoscopy Platforms Bronchoalveolar lavage and bronchial-wash procedures require controlled specimen handling to protect sample quality and reduce exposure during transfer. This transition is integrating closed collection accessories directly with bronchoscopy systems; Verathon introduced SamplePro in 2026 for its BFlex 2 platform as a self-sealing solution for BAL and bronchial-wash collection. The outcome is a more organized bronchoscopy workflow with simpler specimen handling, lower spill risk, and more consistent sample transfer.
01 Higher Burden of Lung Cancer and Chronic Respiratory Diseases and Increasing Need for Bedside Airway Visualization in Critical Care Drive Market Higher incidence of lung cancer, COPD, pneumonia, and other respiratory conditions increases demand for bronchoscopic diagnosis and airway assessment. Hospitals use bronchoscopy to examine suspicious lesions, investigate persistent respiratory symptoms, and support treatment planning for pulmonary diseases. Lung cancer patients, for example, commonly undergo bronchoscopy for airway examination and tissue sampling during diagnosis. This expanding patient pool raises bronchoscopy procedure volumes and strengthens demand for bronchoscopes across pulmonary and oncology departments.Higher numbers of critically ill and mechanically ventilated patients increase demand for bronchoscopes that can provide airway visualization directly at the bedside. Intensive care teams use portable and single-use bronchoscopes for secretion management, difficult airway assessment, and confirmation of airway conditions without transferring unstable patients. ICU applications therefore create recurring equipment requirements across emergency and critical-care settings. This demand-side transition expands bronchoscopes use beyond dedicated endoscopy suites and supports higher procurement by hospitals.
01 Reprocessing and Infection-Control Burden and Limited Access in Smaller and Rural Healthcare Facilities Restrain Market Expansion Reusable bronchoscopes require thorough cleaning, disinfection, drying, storage, and monitoring after every procedure. These steps increase labor needs, turnaround time, and operating costs while placing greater pressure on hospital infection-control systems. Higher reprocessing complexity can reduce procedural efficiency and limit broader bronchoscope adoption.Smaller and rural hospitals often lack dedicated bronchoscopy units, trained specialists, advanced imaging support, and sufficient procedure volumes. Limited infrastructure makes investment in bronchoscopy systems less economical and reduces the ability to offer these procedures locally. This restricts geographic penetration and slows growth of the Bronchoscopes Market.
01 Growth of Bronchoscope Reprocessing, Maintenance, and Lifecycle Service Programs and Wider Adoption of Bronchoscopy Systems in Ambulatory Surgical Centers and Specialty Clinics Offers Growth Opportunities Bronchoscope manufacturers, service providers, and hospital equipment partners can use this opportunity to build recurring revenue beyond initial device sales. Reprocessing support, preventive maintenance, repair contracts, software updates, and lifecycle management packages can deepen long-term customer relationships. Companies such as Olympus and KARL STORZ are well positioned through their established endoscopy service and maintenance networks.Outpatient care settings such as ambulatory surgical centers and specialty clinics offer a new avenue for expanding bronchoscopy services. Compact systems, flexible financing options, and procedure-specific configurations can create revenue through equipment sales, leasing, bundled packages, and recurring service contracts. Companies such as Ambu, Olympus, and Boston Scientific are well positioned to capture this opportunity through their established bronchoscopy portfolios.
01 Device Reliability and Unplanned Procedure Disruptions and Shortage of Specialized Bronchoscopy Skills Bronchoscope manufacturers must maintain reliable performance across complex visualization, navigation, and accessory systems, as equipment failure can interrupt procedures and weaken hospital confidence in newer platforms. Product corrections also create servicing, replacement, and customer-support burdens that can slow commercial expansion. In 2024, Noah Medical recalled certain Galaxy System units after defective power-supply components were found capable of causing unexpected system failure and aborted procedures.Advanced bronchoscopy increasingly requires physicians and clinical teams trained in EBUS, navigation, biopsy techniques, and therapeutic procedures. Uneven availability of such expertise can limit procedure volumes and make hospitals cautious about adopting sophisticated bronchoscopy platforms. Manufacturers consequently face longer customer-training cycles and greater investment in clinical education before they can scale installations across healthcare systems.
August 2025 Fujifilm Healthcare expanded its endoscopy technology offerings with continued advancements in bronchoscopic imaging solutions. The company focused on high-definition visualization, image enhancement technologies, and improved diagnostic capabilities for pulmonary diseases.
July 2025 Boston Scientific expanded its pulmonary endoscopy portfolio through continued development and commercialization of bronchoscopic solutions, including technologies supporting lung cancer diagnosis and minimally invasive respiratory interventions. The company focused on improving navigation, biopsy accuracy, and procedural efficiency.
June 2025 Olympus Corporation continued advancing its respiratory endoscopy portfolio with enhancements to bronchoscopic visualization technologies. The company focused on improving diagnostic accuracy through high-resolution imaging, improved maneuverability, and integration of advanced bronchoscopic tools for pulmonary procedures.
May 2025 Ambu expanded its single-use endoscopy portfolio with continued global adoption of the Ambu® aScope™ Broncho family. The company focused on strengthening disposable bronchoscopy solutions designed to reduce infection risks, improve procedural availability, and support respiratory care workflows.